𝔖 Bobbio Scriptorium
✦   LIBER   ✦

R-GIFOX promising for recurrent or refractory aggressive NHL

Book ID
120849822
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2006
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Low-dose weekly paclitaxel for recurrent
Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma
✍ David A. Rizzieri; Gregory J. Sand; Dean McGaughey; Joseph O. Moore; Carlos DeCa πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 211 KB

## Abstract ## BACKGROUND Many patients with recurrent, intermediate or high‐grade non‐Hodgkin lymphoma (NHL) may not respond to or are not candidates for aggressive salvage chemotherapy. Effective, less toxic regimens are needed. Although high‐dose taxanes have not been reported to be very effect